Zelira Therapeutics Ltd has released a press release.
Suspension from Quotation
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Earlier from Zelira Therapeutics
- Quarterly Activities/Appendix 4C Cash Flow Report
- Transformative US$33M Fundraising into Zeliras HOPE 1 SPV
- Zelira receives $1,070,000 R&D Tax Incentive Scheme Refund
- Preliminary Final Report
- Zelira Therapeutics Secures R&D Loan Facility
Later from Zelira Therapeutics
All Zelira Therapeutics news releasesFollow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics